How Methylene Blue Targets Cancer Metabolism

4 Oct 2025 · 1 min

Watch on YouTube

0:49

In this segment, the speaker introduces methylene blue as a metabolic cancer treatment primer, linking it to the distinctive mitochondrial metabolism of cancer cells. He outlines the broader landscape of metabolic cancer therapies—including dietary sugar restriction, exogenous ketone supplementation, and off‑label metabolic drugs—before highlighting that methylene blue can activate and support metabolic processes that occur outside the mitochondria in cancer cells, thereby addressing specific metabolic demands of tumors.

Chapters

Another area which is related to this mitochondrial difference is methylene blue is a metabolic cancer treatment primer as well. So when we're thinking about the treatment of cancer, we often hear about metabolic treatments for cancer and metabolic treatments for cancer being maybe dietary changes that go on restricting sugar and all the other metabolic type cancer therapies. Or we might use exogenous therapies in metabolism like ketones. And other stuff like that, or may do many other metabolic cancer treatments, which could be off-label drugs or all sorts of stuff. Well, it turns out that some of the metabolic demands that we need outside the mitochondria in the cancer cell are going to be triggered and helped by methylene blue.